A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

NCT02026921 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Epithelial Cancer Recurrent

Interventions

DRUG: Carboplatin
DRUG: Docetaxel

Sponsor

Nordic Society of Gynaecological Oncology - Clinical Trials Unit